ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ARDT vs MRK // OPERATING MARGIN

Ardent Health Inc. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: ARDT 3 — MRK 4
■ METRIC PARITY
operating-margins
34.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARDT VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ARDT MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.50% 20.70% -10.20 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield — 3.42% — TIE /fcf-yield <GO>
Operating Margin ACTIVE — 34.30% — TIE /operating-margins <GO>
Net Profit Margin 2.10% 28.10% -26.00 MRK /net-margins <GO>
Revenue Growth (YoY) 6.00% 1.30% +4.70 ARDT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.19 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.4 51.7 +9.70 ARDT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 11.9x 18.4x -6.50 ARDT /forward-pe <GO>
Enterprise Scale & Market Cap $1.73B $361.02B -$359.29B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ARDT REV MRK REV ARDT GROSS % MRK GROSS % ARDT FCF MRK FCF
FY 2025 $6.32B $65.01B — 74.8% $470.5M $12.36B
FY 2024 $5.97B $64.17B — 76.3% $315.0M $18.10B
FY 2023 $5.41B $60.12B — — $221.7M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARDT // BETA —
MRK // BETA 0.92